Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MTL Cannabis Corp C.MTLC

Alternate Symbol(s):  MTLNF

MTL Cannabis Corp. is focused on crafting cannabis products, including lines of dried flower, pre-rolls and hash marketed. The Company, through its subsidiaries, is engaged in the cultivation and production of cannabis products for recreational and medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions. Its wholly owned subsidiaries include Montreal Medical Cannabis Inc. (Montreal Cannabis), Abba Medix Corp. (Abba), Canada House Clinics Inc. (CHC), and IsoCanMed Inc. (ICM). Montreal Medical is a licensed producer operating from a 57,000 sq ft licensed indoor growing facility in Pointe Claire, Quebec. Abba is a licensed producer in Pickering, Ontario that operates a medical cannabis marketplace. CHC is operating clinics across Canada. ICM is a licensed producer in Louiseville, Quebec growing indoor cannabis in its 64,000 sq. ft. production facility.


CSE:MTLC - Post by User

Bullboard Posts
Comment by SteveB44on Feb 11, 2018 12:40pm
127 Views
Post# 27541036

RE:CHV Coverage-Midas Letter

RE:CHV Coverage-Midas Letterthank you for sharing. this was a great interview and helped me understand their vision for 2018. I look forward to the news coming that he spoke of for 2018. This company has what most of the other companies barely have in place seeing their are already in business with reveunue $$$$.....exisiting customer base with growing client base, seeds being planted in February in new grow facitity to supply their own customer base which should increase profits significantly vs buying outside product and technology that other companies are going to want to access. Under $1 this is a steal considering the small float. as a shareholder I would be expecting this to trade in the $1-$2 range by spring but longer term i think it has much more potential so I will not be selling under $2
Bullboard Posts